Bethany C Wangelin1,2, Peter W Tuerk1,2. 1. Mental Health Service Line, Ralph H. Johnson Veterans Affairs Medical Center (VAMC), Charleston, South Carolina. 2. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: Physiological reactivity to trauma-related cues is a primary symptom of PTSD and can be assessed objectively using script-driven imagery paradigms. However, subjective self-reported symptom measures are the most common outcome indices utilized in PTSD treatment trials and clinic settings. We examined physiological reactivity during a short trauma imagery task as an objective index of response to PTSD treatment, optimized for use in routine clinical care settings. METHODS: Participants were 35 male combat veterans receiving prolonged exposure (PE) therapy in a Veterans Affairs outpatient clinic. In addition to traditional subjective self-reported and clinician-rated symptom measures, patients also completed a script-driven imagery task in which heart rate (HR) and skin conductance (SC) were recorded at three assessment points across treatment. We examined changes in subjective symptom measures and objective trauma-specific physiological reactivity over the course of PE, and investigated the association between pretreatment physiological reactivity and treatment response. RESULTS: Patients who completed PE showed significantly diminished HR and SC reactivity to trauma imagery across therapy. Additionally, individuals showing greater trauma-specific HR reactivity at pretreatment showed greater reductions in subjectively reported PTSD symptoms at posttreatment. CONCLUSIONS: Findings support the utility of physiological reactivity during trauma imagery as an objective outcome measure that has the potential to be incorporated into evidence-based PTSD treatment in routine clinical settings, or prospective studies related to the individualization of care at pretreatment.
BACKGROUND: Physiological reactivity to trauma-related cues is a primary symptom of PTSD and can be assessed objectively using script-driven imagery paradigms. However, subjective self-reported symptom measures are the most common outcome indices utilized in PTSD treatment trials and clinic settings. We examined physiological reactivity during a short trauma imagery task as an objective index of response to PTSD treatment, optimized for use in routine clinical care settings. METHODS:Participants were 35 male combat veterans receiving prolonged exposure (PE) therapy in a Veterans Affairs outpatient clinic. In addition to traditional subjective self-reported and clinician-rated symptom measures, patients also completed a script-driven imagery task in which heart rate (HR) and skin conductance (SC) were recorded at three assessment points across treatment. We examined changes in subjective symptom measures and objective trauma-specific physiological reactivity over the course of PE, and investigated the association between pretreatment physiological reactivity and treatment response. RESULTS:Patients who completed PE showed significantly diminished HR and SC reactivity to trauma imagery across therapy. Additionally, individuals showing greater trauma-specific HR reactivity at pretreatment showed greater reductions in subjectively reported PTSD symptoms at posttreatment. CONCLUSIONS: Findings support the utility of physiological reactivity during trauma imagery as an objective outcome measure that has the potential to be incorporated into evidence-based PTSD treatment in routine clinical settings, or prospective studies related to the individualization of care at pretreatment.
Authors: Tanja Jovanovic; Erica J Duncan; Joanna Kaye; Kristie Garza; Seth D Norrholm; Sabra S Inslicht; Thomas C Neylan; Sanjay J Mathew; Dan Iosifescu; Barbara O Rothbaum; Helen S Mayberg; Boadie W Dunlop Journal: Psychophysiology Date: 2019-02-26 Impact factor: 4.016
Authors: Julianne C Flanagan; Jennifer M Mitchell; Nathaniel L Baker; Joshua Woolley; Bethany Wangelin; Sudie E Back; John R McQuaid; Thomas C Neylan; William R Wolfe; Kathleen T Brady Journal: Contemp Clin Trials Date: 2020-06-16 Impact factor: 2.226
Authors: Peter W Tuerk; Cindy M Schaeffer; Joseph F McGuire; Margo Adams Larsen; Nicole Capobianco; John Piacentini Journal: Curr Psychiatry Rep Date: 2019-10-04 Impact factor: 5.285
Authors: Daniel J Lee; Brian P Marx; Johanna Thompson-Hollands; Matthew W Gallagher; Patricia A Resick; Denise M Sloan Journal: Behav Res Ther Date: 2021-06-24
Authors: Elizabeth R Duval; Jony Sheynin; Anthony P King; K Luan Phan; Naomi M Simon; Brian Martis; Katherine E Porter; Sonya B Norman; Israel Liberzon; Sheila A M Rauch Journal: Depress Anxiety Date: 2020-04-19 Impact factor: 8.128